Cachet Pharmaceuticals Private Limited (Cachet Pharmaceuticals Private Limited)

概览

关联

2

项与 Cachet Pharmaceuticals Private Limited 相关的临床试验

CTRI/2023/02/049625 / Not yet recruitingN/A

Randomized, double blind, placebo controlled clinical study to assess the efficacy & safety of Re-Cart capsules in subjects with knee osteoarthritis. - NIL

开始日期2023-02-13

申办/合作机构

Cachet Pharmaceuticals Private Limited

CTRI/2021/01/030508 / Active, not recruiting临床4期

A phase IV, randomized, multicentre, prospective, open-label, comparative, post-marketing study to evaluate safety & efficacy of combination of Diclofenac, Paracetamol, Trypsin and Chymotrypsin versus combination of Diclofenac and Paracetamol in patients with soft tissue injury.

开始日期2021-01-15

申办/合作机构

Cachet Pharmaceuticals Private Limited

[+1]

100 项与 Cachet Pharmaceuticals Private Limited 相关的临床结果

登录后查看更多信息

0 项与 Cachet Pharmaceuticals Private Limited 相关的专利（医药）

登录后查看更多信息

100 项与 Cachet Pharmaceuticals Private Limited 相关的药物交易

登录后查看更多信息

100 项与 Cachet Pharmaceuticals Private Limited 相关的转化医学

登录后查看更多信息